Object. Intracerebral hemorrhage (ICH) is an uncommon complication of carotid endarterectomy (CEA), and carries a high rate of mortality and morbidity. Traditionally, attention has been focused on the cerebral hyperperfusion syndrome (HPS) as the leading cause of ICH after CEA. Other mechanisms, such as a perioperative cerebral ischemic event, cerebral infarction, and use of postoperative anticoagulation therapy, may also be important.
AROTID endarterectomy is increasingly performed following study results demonstrating a benefit associated with CEA in patients with symptomatic, severe (Ͼ 70% diameter) CA stenosis, and a possible benefit in patients with asymptomatic CA stenosis. 1, 2 An ICH following CEA occurs in fewer than 1% of cases, may account for up to one quarter of all postoperative complications, 4, [10] [11] [12] 15, 16 and has a high morbidity and mortality rate in community-based series. 7, [10] [11] [12] 15 Some characteristics of patients who have had an ICH have been identified and compared with those in controls. The cerebral HPS following CEA has been proposed as the main mechanism, and usually occurs following repair of a severe CA stenosis. 4, 7, 11 Reperfusion of the hemisphere into an acute cerebral infarct, 13 and anticoagulation therapy 7, 10, 11 may be other important risk factors.
In this retrospective case control study we reviewed the clinical and radiological characteristics of patients with an ICH following CEA, assessing the risk factors leading to ICH. Moreover, the occurrence of ICH following CEA at our institution was compared with two reports from previous decades. 11, 16 Our goal was to determine whether factors such as the time between ischemic events and CEA, ischemic stroke as opposed to TIA, and the results of perioperative studies were different in the patients who had an ICH compared with patients without hemorrhage following CEA.
Clinical Material and Methods

Inclusion Criteria
We used computerized record identification (International Classification of Disease-9) to search for all patients who underwent a CEA performed by the cerebrovascular neurosurgeons and vascular surgeons at the Mayo Clinic between January 1990 and December 1999. Using all possible classification codes for hemorrhage, these patients were then assessed for the occurrence of ICH. The cases were limited to ICH occurring in the 30 days following CEA, and records were available for all 12 patients who fulfilled these criteria.
The control group was obtained from a database of patients who underwent CEA and in whom both ultrasound and MR imaging of the CA with gadolinium bolus were performed during the same decade as those in the ICH group. The database is representative of all CEAs performed at our institution. Because it has been suggested in previous studies that ICH is essentially a result of the reopening of severe CA stenosis in symptomatic patients, 4, [10] [11] [12] 15, 16 only control patients with symptomatic, severe stenosis were selected from the database. Severe CA stenosis was defined as greater than 70% stenosis 1 identified on both imaging methods. Forty-four patients in the database who had severe symptomatic CA stenosis met these criteria and served as the control group for the present study.
Patient Population
A total of 2747 CEAs were performed in 2468 patients between 1990 and 1999 at our institution. Twelve patients (0.4%) with an ICH following CEA were identified. In all 12 cases, the ICH occurred ipsilaterally to the side of the CEA, with individual events occurring from the day of the operation until 8 days later (mean 3.5 days). Specific details of the 12 cases and 44 controls, including demographic features, risk factors, and CBF values, are included in Table 1. Details regarding the timing of the CEA in relation to a previous ischemic event and in relation to the ICH, CBF values, site and size of the ICH, and patient outcome are given in Table 2 .
Men and women were equally represented. The mean age of the patients with ICH was 65 years (range 51-79 years). Eleven patients suffered an ipsilateral TIA or stroke prior to CEA; of these 11 instances, one was a transient retinal and four were transient hemispheric ischemic events referable to the site of the stenosis. Severe or near-occlusive CA stenosis was identified in all 12 cases: nine with conventional angiography and one by using MR angiography with gadolinium bolus. The other two patients had severe CA stenosis that was identified using duplex CA ultrasonography alone. An intracranial aneurysm or arteriovenous malformation was present in none of the cases. Two patients with ICH and two controls underwent intraoperative shunt placement. Eight patients with ICH (66%) underwent complete 133 Xe CBF studies, with one case lacking a record of the postocclusion pressure and CBF studies not performed in three cases. Also, 133 Xe CBF studies were available in 28 (64%) of the controls.
The demographic features of age and sex were recorded, along with the presence of the known cerebrovascular risk factors of hypertension, cigarette smoking, and diabetes. The degree of CA stenosis and means of detection were recorded, along with the date and site of the ipsilateral ischemic event and the time of the neuroimaging session closest to the CEA. The CEAs were performed using standard methods. A bolus of heparin, usually 5000 U, was given at the start of the procedure; protamine was not generally given at the conclusion of the CEA. Decisions regarding shunt placement were at the surgeon's discretion and were based on clinical considerations and the presence of ischemic changes on the EEG studies.
Monitoring Methods Used
The CBF was measured with the aid of an intracarotid injection of xenon-133 and was determined at baseline, occlusion, and following CEA, as previously described. 16 The
133
Xe flow studies were performed by most but not all surgeons, and were used in the clinical decision-making process for shunt placement, but were not part of management strategies to reduce postoperative hemorrhage. All patients underwent EEG monitoring during the CEA, and changes in the EEG values with clamping were noted, along with the insertion of a shunt. In the ICH group, the date of the hemorrhage was noted, along with its site. In both ICH and control groups, an assessment of hypertension postoperatively compared with preoperatively, occurrence of seizures, and documentation of headache were made after a detailed review of medical records.
Outcome Classification
The mRS was used to classify outcome following ICH; outcome data in survivors was tabulated at 6 months. An mRS grade of 2 or less was defined as a good outcome and denoted independence in activities of daily living. An mRS grade of 3 or 4 was considered a moderate outcome, and an mRS grade of 5 was equated with severe disability and a bedridden state requiring constant nursing care. An mRS grade of 6 was equated with death.
The postoperative use of anticoagulation therapy with intravenously administered heparin and orally administered warfarin was noted. Nearly all patients were receiving aspirin before the CEA in both the ICH and control groups. Neuroimaging was available in all cases, and the original films were reviewed by two of the authors (T.P. and R.D.H.).
Assessment of HPS
Features of HPS were defined as postoperative hyper-
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Hemorrhage following carotid endarterectomy 965 tension in association with severe headaches, confusion, or seizures. 11 Hypertension following CEA in patients with preexisting hypertension was defined as a greater than 20-mm Hg increase in baseline systolic BP, and in patients without prior hypertension it was defined as a systolic BP greater than 160/90 mm Hg, in both instances when present on more than half of daily recordings. Management of elevated BP was generally accomplished with oral antihypertension medication at the discretion of the surgeon. The HPS was also considered to be present if the results of the 133 Xe flow studies showed a greater than 100% increase (that is, a doubling) in CBF in the measurements obtained before and after clamping. Patients were considered to have experienced an intraoperative cerebral ischemic event if a new or worsening clinical deficit was noted when they regained consciousness following CEA.
Statistical Analysis
We compared continuous variables by using the Wilcoxon rank-sum test and categorical variables by using the chisquare test, or, if any of the expected counts were less than five, the Fisher exact test. A probability value less than or equal to 0.05 was considered significant.
Results
There was no difference in sex or history of hypertension, cigarette smoking, or diabetes between the patients with ICH and controls ( Table 1 ). Five of the eight patients with ICH in whom CBF studies were performed had a greater than 100% increase in 133 Xe-measured CBF following CEA compared with baseline (subsequently referred to as doubling). There was a difference between the ICH and control groups in the number of patients who experienced a doubling of CBF after CEA (p = 0.006). There was also a difference in the mean change in CBF before and after CEA, between the patients with ICH (25 ml/100 g cerebral tissue/minute) and the controls (6 ml/100 g cerebral tissue/ minute).
The HPS, operative ischemia, anticoagulation therapy, and prior cerebral infarction were identified as the mechanisms for ICH, either alone or in combination. The HPS was a contributing mechanism in seven cases; it was clinically evident in three cases, in which imaging at the time of symptoms did not initially reveal hemorrhage, and it was evident from doubling of CBF in four more cases. When HPS was the major cause of ICH (five patients), the hemorrhage occurred between Day 3 and Day 8 following CEA. Of these patients, CBF studies that showed doubling were performed in three, but in only one of these three cases were there clinical features of HPS. The ICH occurred in the anterior circulation but generally did not bleed directly into the area of infarction when HPS was the major mechanism (Fig. 1) . In one case in which the CEA was performed 4 days after the cerebral infarct, however, serial imaging appears to reveal the hemorrhage extending into the area of infarction and surrounding brain tissue (Fig. 2) . More than half of the patients with ICH in whom HPS was the chief mechanism died, and two achieved independence.
In four of the 12 patients with ICH, an operative cerebral ischemic event was a contributing mechanism. (Only two members of the control group suffered a cerebral ischemic event during or following surgery.) The four patients with ICH suffered an intraoperative ischemic event that was thought to be embolic, based on their clinical deficit on awakening from surgery and the fact that imaging studies did not initially show an ICH. A postoperative conventional angiographic study obtained in one case showed an embolus in a distal artery (Fig. 3) . The lack of ischemic changes with clamping on EEG studies argues against hypoperfusion as the mechanism of ischemia. In all four patients the risk of ICH was likely to have been exacerbated by either anticoagulation therapy with therapeutic intravenously administered heparin (three cases) or HPS (two cases). Half of these patients died and one achieved relative independence.
In one patient, anticoagulation therapy with intravenously administered heparin for a presumed postoperative pulmonary embolus contributed to the ICH without other identifiable mechanisms, although CBF studies were not performed in this patient. Six of the patients with ICH and none of the control group received postoperative anticoagulation therapy with intravenously administered heparin (p Ͻ 0.001) for presumed embolic cerebral ischemia or pulmonary embolism. In each of these six cases, results of the coagulation studies were not beyond the accepted therapeutic window. Patients were routinely given 5000 U of heparin at the time of the CEA that was generally not reversed with protamine. No ICH occurred within 6 hours of the heparin bolus given at the start of the CEA.
In one case with no alternative cause, an ICH bled into an area of previous infarction; this led us to examine the relationship between an earlier ischemic event and ICH. Six of the patients with ICH and 13 in the control group had suffered a stroke rather than a TIA as the reason for the CEA (p = 0.13). Three of the six patients with ICH who suffered a stroke underwent operation within 2 weeks of the infarct, with the ICH occurring in the vicinity of the area of recent infarction in two of these patients (Fig. 2) . No difference was found between the patients with ICH and controls in the absolute time that elapsed between the stroke and the CEA, or in those who underwent operation within two weeks of a stroke (p = 0.34).
Discussion
At our institution, ICH occurred after CEA in approximately 0.4% of cases and entailed high mortality and morbidity rates. This figure approximates the incidence of this CEA complication in symptomatic patients in communitybased series. 4, [10] [11] [12] 15, 16 Of the 1415 patients in the surgical arm of The North American Symptomatic Carotid Endarterectomy Trial, 328 of whom had severe CA stenosis, three patients, all with severe stenosis, suffered an ICH within 8 days of the CEA. 7 There has been no significant change in the incidence of ICH when compared with previous studies from this institution. 11, 16 We found that ICH following CEA typically occurs within the 1st week, in the identifiable settings of hyperperfusion, a perioperative cerebral ischemic event, and anticoagulation therapy. In our patients, two or more of these mechanisms usually contributed. Consistent with other studies, ICH occurred in symptomatic patients following reopening of a severe arterial obstruction and was ipsilateral to the CEA. [4] [5] [6] [7] [8] [10] [11] [12] [13] [14] [15] When compared with a matched control group, HPS was present to a greater degree in the patients with ICH. Impaired cerebral autoregulation in patients with severe CA stenosis may be the first step leading to HPS. After CEA, reperfusion in the distal vascular bed could lead to an increase in intracapillary pressure in already maximally dilated vessels. This results in a disruption of capillary endothelial cells, breakdown of the BBB, and edema formation in the cerebral white matter, [3] [4] [5] 17 which is most pronounced 2 to 4 days after CEA. 13 The result of this process may be an ICH as detailed in Fig. 4 , with cerebral ischemia and anticoagulation therapy important contributors to the cascade leading to ICH.
In this study, the clinical features of HPS, such as severe headache, acute confusional state, and seizures, were present in only one quarter of the patients before ICH. With control of hypertension, clinical features of HPS should be rarely identifiable prehemorrhage. There is a subset of patients, however, who experience increased CBF identified during a CEA and who are at risk of a subsequent ICH, but who do not manifest the symptoms and signs of HPS. In
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Hemorrhage following carotid endarterectomy fact, in our study, two of three patients with increased CBF did not display the clinical features of HPS in the week following CEA. The clinical features of HPS either represent the severe end of the spectrum of hyperperfusion or there may be an individual threshold at which the cerebral microvascular structures can withstand this increased CBF.
An intraoperative cerebral ischemic event was a notable factor preceding ICH in this study. Hemorrhage in this setting was compounded by the HPS and/or anticoagulation therapy, arguing against the theory that the mechanism of ICH is solely hemorrhagic transformation of an infarct. An intraoperative cerebral ischemic event, in which damage to the microvasculature also occurs, could compound the cascade of events caused by increased CBF following reopening of a tight stenosis. At present, there is no therapeutic mechanism that can be used to limit damage to the microvasculature once it has occurred, and therefore the aim should be to limit potential exacerbating factors as outlined later.
In most reports of patients with HPS, the ICH appears to extend into the territory of the major artery supplying the infarcted area, with evidence of nearby ischemia, rather than directly into the infarct. 10, 11, 13 In our study ICH clearly bled into the region of previous infarction on neuroimages obtained in three cases, in two of which there was a short period between the infarct and CEA. It has been observed in patients who have had a prior ischemic stroke that injury is not just limited to the glial cells and neurons, but is also present in the microvascular structures, particularly the basal lamina of the endothelial cells. 9 A recent ischemic stroke, as was present in two patients in our study, could further increase the risk of ICH because the breakdown of the BBB has been associated with proliferating immature capillaries as shown by contrast enhancement on computerized tomography scans or MR images. 6 In our study, with its small number of patients with ICH, we did not demonstrate that an earlier or recent stroke is found more commonly in the ICH group than in the controls.
Long-standing hypertension and amyloid deposition may predispose to microvasculature damage 9 and compound the risk associated with HPS. A history of hypertension has been considered to be a risk factor for ICH following endarterectomy. 11 Although the number of cases is small, prior hypertension was documented in a similar proportion of patients with ICH and controls. It is most likely that prior systemic hypertension by itself is a relatively minor factor leading to ICH after CEA.
In this study we found that more than a doubling of CBF is a risk factor for subsequent ICH. In patients with more than a doubling of CBF, the following management strategies may be important in the 2 weeks following CEA: 1) careful monitoring of BP and control of hypertension following the CEA; 2) avoidance of anticoagulation therapy; and 3) patient education regarding the importance of reporting symptoms such as major headache, confusion, or seizures that occur in the first 2 weeks after CEA. In patients with postoperative hypertension, BP monitoring should be performed initially during hospitalization and, in a subset of patients, outpatient monitoring may be required. Control of hypertension is generally achievable with oral medication, but consultation with hypertension specialists may occasionally be required.
The limitations of this study deserve mention. We did not determine the occurrence of cerebral ischemic events or HPS across the entire study population. In this retrospective study it is possible that we may not have recognized some cases of ICH because of the relatively infrequent oc- currence of this complication. Subclinical ICH and instances of hemorrhagic transformation of an infarct in patients in whom cerebral imaging was not performed may have been missed.
Multiple factors may determine the risk of ICH after a CEA. Hyperperfusion, perioperative cerebral ischemia, and anticoagulation therapy are identifiable antecedents to the hemorrhage. It remains to be determined whether intraoperative CBF monitoring and avoidance of risk factors such as postoperative hypertension and anticoagulation therapy will reduce the already low risk of ICH following a CEA.
